Qilu Pharmaceuticals company information, Employees & Contact Information

Sagent and Qilu Announce Strategic Collaboration to Expand Access to Critical Injectables in U.S. PR Newswire

Fierce Pharma Asia—Pfizer partner's trial win; Roche's $300M China plant; Hengrui's HK IPO plan Fierce Pharma

Minghui Pharma announces oncology agreement worth $185 M with Qilu Pharma in Greater China BioSpectrum Asia

Preliminary Results of Qilu Pharmaceutical's Phase Ia Study on GPRC5D/CD3-Targeting Bispecific Antibody QLS32015 Unveiled at 2024 ASH Annual Meeting PR Newswire

Chinese Company Qilu Pharmaceutical Is Supplying the Anti-Cancer Drug Cisplatin Injection to the United States Again Yahoo Finance

Minghui and Qilu Pharmaceutical to advance MHB088C in Greater China Pharmaceutical Technology

Arbutus and Qilu Pharmaceutical Enter into an Exclusive GlobeNewswire

Results from the Clinical Trial of Qilu Pharmaceutical's Novel Anticancer Agent Iparomlimab and Tuvonralimab (QL1706) Featured in Oral Presentation at the ESGO Annual Meeting BioSpace

Arbutus regains China rights to potential functional hep B cure as part of strategic rethink Fierce Biotech

Pfizer & Astellas Sue Qilu Pharma Over Xtandi NAVLIN DAILY

CellOrigin Biotech and Qilu Pharmaceutical to develop CAR-iMAC cell therapy Labiotech.eu

FDA clears more chemotherapy imports from China's Qilu amid shortage of key cancer meds Fierce Pharma

EC approval of ranibizumab biosimilar Rimmyrah Generics and Biosimilars Initiative

Qilu Pharmaceutical Announces Results from Phase I Clinical Study for Its Novel Bispecific Antibody QLS31905 at ESMO Immuno-Oncology Congress BioSpace

FDA to allow temporary overseas production to shore up supplies of chemo drug Fierce Pharma

Qilu Pharmaceutical Showcases QL1706 Clinical Trial Outcomes in Oral Presentation at ESGO 2024 PR Newswire

Qilu Pharmaceutical to Showcase Novel Anti-Cancer Drug QL1706 at ESMO Congress 2023 BioSpace

Cend Therapeutics and Qilu Pharmaceutical Announce Partnership GlobeNewswire

10 killed in explosion at Chinese pharma plant Fierce Pharma

ECI Pharmaceuticals LLC Signs Agreement to Be Exclusive U.S. Distributor of Generic Cialis® GlobeNewswire

Shanghai Qilu Pharmaceutical Research and Development Centre describes new IRAK-4 degradation inducers BioWorld MedTech

Qilu Pharmaceutical announces the latest results from its clinical study on QL1706, in combination with chemotherapy, as a first-line treatment for recurrent or metastatic cervical cancer PR Newswire

Warminster Biopharma Firm Ends $285M Licensing Deal with Chinese Company BUCKSCO.Today

Sanofi, AZ, Lilly and more win business in China's expanded cut-price purchase program Fierce Pharma

FDA commissioner heralds end to US shortfall of chemo drug cisplatin Fierce Pharma

Rimmyrah Joins Roster of Lucentis Biosimilars Awaiting Reimbursement in Italy NAVLIN DAILY

Qilu starts phase III trial for denosumab copy biological Generics and Biosimilars Initiative

Amid shortage, Accord Healthcare restarts production of cancer drug cisplatin Fierce Pharma

Arbutus terminates potential $285M licensing deal with Chinese drug company The Business Journals

Pharmaceutical companies face steeper price cuts in China as country expands drug bulk-buying scheme nationwide: report FirstWord Pharma

US FDA to temporarily import Chinese cancer drug to ease shortage Business Standard

CellOrigin Biotech collaborates with Qilu Pharma to develop CAR-iMAC Cell Therapy Indian Pharma Post

U.S. drug shortages highlight dependence on China, gray supply chains The China Project

Astellas, Pfizer Sue to Block Copies of Lucrative Xtandi Drug Bloomberg Law News

China Approves Generic Nplate NAVLIN DAILY

National cancer group reports widespread chemo shortages, calls on government and industry to help resolve them Fierce Pharma

China likes what it sees in Boston biotech The Boston Globe

NPC deputy Li Yan introduces Qilu Pharmaceutical to foreign media 闪电新闻

Lonza plagued by supply problems after China plant explosion Fierce Pharma

EMA recommends approval of ranibizumab biosimilar Rimmyrah Generics and Biosimilars Initiative

Pharma plant explosion in India kills 3 workers Fierce Pharma

Thrombocytopenia Pipeline Experiences Momentum: GlobeNewswire

S. Korea's Peptron licenses global development of ADCs for cancer treatment BioSpectrum Asia

HUAXING CHEMICAL AgriBusiness Global

Generic version of AZ’s Iressa launched in China PMLiVE